Evidence base: Tyrosinase inhibition multiple in vitro and clinical studies confirm glutathiones capacity to inhibit tyrosinase and shift melanogenesis toward lighter phaeomelanin production Published RCTs randomised controlled trials have documented measurable skin lightening outcomes with IV glutathione administration compared to placebo in Asian skin type populations, including Fitzpatrick IIIV the most prevalent skin types among Mumbai patients Hepatic and antioxidant support extensive published evidence from hepatology and immunology supports IV glutathiones systemic detoxification and antioxidant mechanisms Safety profile when administered in appropriate concentrations by qualified medical professionals, IV glutathione has a well-established safety record across international clinical practice At Brilliance Cosmocare, IV Glutathione therapy is administered strictly within evidence-supported concentration ranges by trained medical staff not administered in the unregulated, high-dose formats that carry documented safety concerns
For the foundational coverage of each compound individually, see What Is AOD-9604
Additives, Fillers, and Hidden Stimulants Not all supplements are created equal
This growing public health challenge highlights the limitations of existing therapies and the pressing demand for disease-modifying treatments that go beyond symptomatic relief (Wang et al., 2024)
Arch Pharm 358(1):e2400702 Thabet NM, Abdel-Rafei MK, Askar MA et al (2023) Nanocomposite zinc oxide@ -linolenic acid-canagliflozin-fucoxanthin and/or -radiation perturbs key metabolic effectors and suppresses the proliferation of breast cancer cells in vitro
Based on the results on the Nissl staining, the research team was able to conclude that treatment with Dihexa attenuated the rate of neuronal loss in the brains of APP/PS1 mice [1]
